D. E. Shaw & Co., Inc. Rocket Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 992,825 shares of RCKT stock, worth $3.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

992,825

Holding current value

$3.97 Million

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.33 - $8.01 $2.31 Million - $7.95 Million	992,825 New	992,825 $2.43 Million
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $722,162 - $1.03 Million	-43,530 Reduced 50.77%	42,215 $838,000
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $1.52 Million - $2.18 Million	-96,417 Reduced 52.93%	85,745 $1.47 Million
Q4 2022 Feb 14, 2023	SELL	$15.5 - $22.76 $4.13 Million - $6.06 Million	-266,180 Reduced 59.37%	182,162 $3.56 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $3.22 Million - $4.79 Million	260,041 Added 138.1%	448,342 $7.16 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $25,559 - $53,431	-3,211 Reduced 1.68%	188,301 $2.59 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $526,636 - $947,626	40,018 Added 26.42%	191,512 $3.04 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $730,388 - $1.22 Million	-33,940 Reduced 18.3%	151,494 $3.31 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $399,893 - $714,178	-14,584 Reduced 7.29%	185,434 $5.54 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $4.19 Million - $5.02 Million	-106,232 Reduced 34.69%	200,018 $8.86 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $536,895 - $816,493	-12,388 Reduced 3.89%	306,250 $13.6 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $2.3 Million - $5.88 Million	98,759 Added 44.92%	318,638 $17.5 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $129,621 - $180,774	-6,323 Reduced 2.8%	219,879 $5.03 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $250,402 - $425,045	18,799 Added 9.06%	226,202 $4.73 Million
Q1 2020 May 15, 2020	BUY	$9.71 - $25.11 $1.83 Million - $4.75 Million	188,976 Added 1025.54%	207,403 $2.89 Million
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $203,986 - $446,486	18,427 New	18,427 $419,000
Q1 2019 May 15, 2019	SELL	$13.45 - $19.01 $150,182 - $212,265	-11,166 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.21 - $23.53 $155,706 - $326,831	-13,890 Reduced 55.44%	11,166 $165,000
Q3 2018 Nov 14, 2018	SELL	$18.5 - $25.49 $604,839 - $833,370	-32,694 Reduced 56.61%	25,056 $617,000
Q2 2018 Aug 14, 2018	SELL	$14.58 - $23.0 $1.19 Million - $1.87 Million	-81,450 Reduced 58.51%	57,750 $1.13 Million
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $1.63 Million - $2.67 Million	139,200 New	139,200 $2.61 Million

Others Institutions Holding RCKT

# of Institutions

219

Shares Held

98.7M

Call Options Held

611K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $303M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account